Free Cash Flow

Free cash flow

Merck & Co. Free cash flow decreased by 73.3% to $1.82B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 27.4%, from $2.51B to $1.82B. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 9.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionFree Cash Flow
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026

How to read this metric

An increase suggests strong operational efficiency and the ability to self-fund future innovation or return capital to shareholders, while a decrease may indicate heavy capital expenditure cycles or declining operational profitability.

Detailed definition

Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...

Peer comparison

High-growth semiconductor and AI infrastructure peers typically prioritize reinvestment, so free cash flow margins are often compared against R&D intensity and capital expenditure requirements of industry rivals.

Metric ID: cf_free_cash_flow

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$505.00M$3.63B$3.89B$3.78B$3.17B$4.48B$3.28B$332.00M$2.74B$6.82B$0.00$2.23B$4.85B$8.51B$2.51B$1.17B$2.53B$6.84B$1.82B
QoQ Change+617.8%+7.2%-2.8%-16.0%+41.1%-26.7%-89.9%+725.0%+148.8%-100.0%+117.4%+75.6%-70.5%-53.4%+115.8%+170.3%-73.3%
YoY Change+528.3%+23.5%-15.6%-91.2%-13.7%+52.3%-100.0%+571.4%+76.9%+24.8%-47.4%-47.8%-19.7%-27.4%
Range$0.00$8.51B
CAGR+33.0%
Avg YoY Growth+65.3%
Median YoY Growth-14.6%

Frequently Asked Questions

What is Merck & Co.'s free cash flow?
Merck & Co. (MRK) reported free cash flow of $1.82B in Q4 2025.
How has Merck & Co.'s free cash flow changed year-over-year?
Merck & Co.'s free cash flow decreased by 27.4% year-over-year, from $2.51B to $1.82B.
What is the long-term trend for Merck & Co.'s free cash flow?
Over 4 years (2021 to 2025), Merck & Co.'s free cash flow has grown at a 9.3% compound annual growth rate (CAGR), from $8.67B to $12.36B.
What does free cash flow mean?
The cash a company has left over after paying for its operating expenses and capital investments.